Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03743688 · ClinicalTrials.gov registry record
Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults
A clinical trial of Influenza and Influenza, Human, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT03743688 is a study of Influenza and Influenza, Human that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 10 participants, below the 36,804-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03743688, a study of Influenza and Influenza, Human, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the body's immune response at different time points to an FDA-approved seasonal influenza vaccine. By better understanding the way the immune system responds to the influenza vaccine, the investigators can design more effective vaccines against influenza.
Conditions Studied
Interventions
- BIOLOGICAL Influenza Vaccine Recipients
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-12-04 |
| Est. Completion | 2019-07-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03743688
The ClinicalTrials.gov registry entry for NCT03743688 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 36,804-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Influenza appearing as the primary indexed condition, and to 1 intervention - of which Influenza Vaccine Recipients is the first listed.
NCT03743688 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT03743688 about?
NCT03743688 is a clinical study titled "Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults". The purpose of this study is to evaluate the body's immune response at different time points to an FDA-approved seasonal influenza vaccine. By better understanding the way the immune system responds to the influenza vaccine, the investigators can design more effective vaccines against influenza.
What is the current status of trial NCT03743688?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2018-12-04. Estimated completion is 2019-07-26.
What conditions does trial NCT03743688 study?
This clinical trial studies the following conditions: Influenza, Influenza, Human, Influenza a, Vaccine Reaction, Influenza Type B.
What interventions are being tested in trial NCT03743688?
The interventions under investigation include: Influenza Vaccine Recipients (BIOLOGICAL).
Who is sponsoring clinical trial NCT03743688?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03743688 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
pH1N1 Blinded Challenge Study
RECRUITING · Phase 1
-
B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults
RECRUITING · Phase 4
-
High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)
RECRUITING · Phase 2
-
Influenza Immunization in Adults Over Age 75
RECRUITING · NA
-
H5N1 Milk Detection Study
RECRUITING · NA
-
Screening for LID Clinical Studies Unit Healthy Volunteer Protocols
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.